Several studies have shown an increased risk of cardiovascular events during lower respiratory tract infections [29, 30], and specifically during infection with SARS-CoV-2 [3, 31], a finding supported by the high number of patients with elevated cTnT and NT-proBNP in both groups in our study. This evidence concerns the gene NPPB and infection.